Chair
Member
Audit Committee Position

Jess Roper

Jess Roper was appointed to the BIOLASE Board of Directors in June 2018 and serves as the Chairman of its Audit Committee. Mr. Roper has considerable financial and audit experience in the sectors of medical devices, life sciences, technology, manufacturing, and financial institutions. He joined San Diego-based Dexcom, Inc., in 2005 and he most recently served as its Senior Vice President and Chief Financial Officer, retiring in April 2017. Dexcom is a developer and marketer of continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital. During his tenure, Dexcom transitioned from a pre-revenue privately held medical device company to a multi-national, publicly traded entity with 2016 worldwide revenues of $573 million. Mr. Roper previously held financial management positions with two other publicly traded companies and one venture funded company and has extensive capital markets experience. Earlier in his career, Mr. Roper was an auditor with PricewaterhouseCoopers, and a bank and information systems examiner with the Office of the Comptroller of the Currency. Mr. Roper earned a Master of Science in Corporate Accountancy and a Bachelor of Science in Business Administration in Finance from San Diego State University. He is a Certified Public Accountant in California and a member of the Corporate Directors Forum.

Chair

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Member

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Member

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.

Member

Audit Committee Charter

Download
Compensation Committee Position

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Chair

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Member

Compensation Committee Charter

Download
Nominating and Corporate Governance Committee Position

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Chair

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Member

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.

Member

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Member

Jess Roper

Jess Roper was appointed to the BIOLASE Board of Directors in June 2018 and serves as the Chairman of its Audit Committee. Mr. Roper has considerable financial and audit experience in the sectors of medical devices, life sciences, technology, manufacturing, and financial institutions. He joined San Diego-based Dexcom, Inc., in 2005 and he most recently served as its Senior Vice President and Chief Financial Officer, retiring in April 2017. Dexcom is a developer and marketer of continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital. During his tenure, Dexcom transitioned from a pre-revenue privately held medical device company to a multi-national, publicly traded entity with 2016 worldwide revenues of $573 million. Mr. Roper previously held financial management positions with two other publicly traded companies and one venture funded company and has extensive capital markets experience. Earlier in his career, Mr. Roper was an auditor with PricewaterhouseCoopers, and a bank and information systems examiner with the Office of the Comptroller of the Currency. Mr. Roper earned a Master of Science in Corporate Accountancy and a Bachelor of Science in Business Administration in Finance from San Diego State University. He is a Certified Public Accountant in California and a member of the Corporate Directors Forum.

Member

Nominating and Corporate Governance Committee Charter

Download
Clinical Committee of the Board Position

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Chair

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Member

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.

Member

Jess Roper

Jess Roper was appointed to the BIOLASE Board of Directors in June 2018 and serves as the Chairman of its Audit Committee. Mr. Roper has considerable financial and audit experience in the sectors of medical devices, life sciences, technology, manufacturing, and financial institutions. He joined San Diego-based Dexcom, Inc., in 2005 and he most recently served as its Senior Vice President and Chief Financial Officer, retiring in April 2017. Dexcom is a developer and marketer of continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital. During his tenure, Dexcom transitioned from a pre-revenue privately held medical device company to a multi-national, publicly traded entity with 2016 worldwide revenues of $573 million. Mr. Roper previously held financial management positions with two other publicly traded companies and one venture funded company and has extensive capital markets experience. Earlier in his career, Mr. Roper was an auditor with PricewaterhouseCoopers, and a bank and information systems examiner with the Office of the Comptroller of the Currency. Mr. Roper earned a Master of Science in Corporate Accountancy and a Bachelor of Science in Business Administration in Finance from San Diego State University. He is a Certified Public Accountant in California and a member of the Corporate Directors Forum.

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Jonathan T. Lord, M.D.

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for Biolase (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Jess Roper

Jess Roper was appointed to the BIOLASE Board of Directors in June 2018 and serves as the Chairman of its Audit Committee. Mr. Roper has considerable financial and audit experience in the sectors of medical devices, life sciences, technology, manufacturing, and financial institutions. He joined San Diego-based Dexcom, Inc., in 2005 and he most recently served as its Senior Vice President and Chief Financial Officer, retiring in April 2017. Dexcom is a developer and marketer of continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital. During his tenure, Dexcom transitioned from a pre-revenue privately held medical device company to a multi-national, publicly traded entity with 2016 worldwide revenues of $573 million. Mr. Roper previously held financial management positions with two other publicly traded companies and one venture funded company and has extensive capital markets experience. Earlier in his career, Mr. Roper was an auditor with PricewaterhouseCoopers, and a bank and information systems examiner with the Office of the Comptroller of the Currency. Mr. Roper earned a Master of Science in Corporate Accountancy and a Bachelor of Science in Business Administration in Finance from San Diego State University. He is a Certified Public Accountant in California and a member of the Corporate Directors Forum.

Dr. Martha Somerman

Dr. Martha Somerman is the Chief Field Editor of Frontiers in Dental Medicine. She was the Director, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH) from August 2011 to December 2019 and then served as a senior advisor for NIDCR until her retirement on May 31, 2021. In addition, she was the Principal Investigator for the Laboratory of Oral Connective Tissue Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, from August 2011 to May 31, 2021. Her laboratory team focused on identifying factors controlling the development of the periodontal complex and applying this knowledge toward developing strategies to regenerate periodontal tissue lost as a consequence of disease. Prior to becoming NIDCR director, Dr. Somerman was Dean of the University of Washington School of Dentistry, a position she held since 2002. From 1991 to 2002, Dr. Somerman was on the faculty of the University of Michigan School of Dentistry where she served as a professor and chair of periodontics/prevention and geriatrics. From 1984 to 1991, Dr. Somerman was on the faculty of the University of Maryland College of Dental Surgery. Dr. Somerman received a bachelor's degree in biology and a D.D.S. from New York University, a Masters in Environmental Health from Hunter College, and a Ph.D. in Pharmacology from the University of Rochester. She completed her periodontal residency at the Eastman Dental Center in Rochester, New York and is a diplomat of the American Board of Periodontology.

Dr. Kathleen T. O'Loughlin

Dr. Kathleen T. O'Loughlin is currently the Executive Director of the American Dental Association and is retiring from the American Dental Association by the end of this year. Previously, Dr. O'Loughlin served as Chief Dental Officer of United Health Group, and from 2002 to 2008 she served as President and Chief Executive Officer of Delta Dental of Massachusetts. Dr. O'Loughlin serves on the Board of Directors of the American Dental Association and previously served as a Trustee at Tufts University. Dr. O'Loughlin received her Masters in Public Health from Harvard University, a Doctor of Dental Medicine, Summa Cum Laude, from Tufts University, and a B.A from Boston University.

Kenneth P. Yale, D.D.S., J.D.

Dr. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense (DOD), a position he has held since March 2020. Previously Dr. Yale held positions as the Chief Clinical Officer at Delta Dental, Vice President of Clinical Solutions and Medical Director at Aetna, Chief Executive at UnitedHealth Group MSO, and Corporate VP of Matria Healthcare and CorSolutions. He was also Founder and CEO of Advanced Health Solutions, CEO of Health Solutions Network, and SVP and General Counsel for EduNeering, an Internet content company. Dr. Yale also served as Chief of Staff of the White House Office of Science and Technology and Executive Director of the White House Domestic Policy Council. Dr. Yale received a D.D.S. in Dentistry from the University of Maryland and a J.D. in Law, Science and Medicine from Georgetown University.